Connect with us

Health

Jessye Norman’s Family Sue Over Treatment That Allegedly Left Her Paralysed

Jessye Norman’s family sue over treatment that allegedly left her paralysed

She had a voice described as a “grand mansion of sound”, won four Grammy awards and thrilled audiences in the world’s opera house – but suddenly stopped performing in 2015.

When Jessye Norman died four years later at the age of 74, her family said she had passed away from septic shock and multi-organ failure secondary to complications of a spinal cord injury she had sustained in 2015. The circumstances surrounding the injury and disappearance from public life were never explained.

However, it can be revealed that Norman’s brother is suing two renowned doctors and a leading London private hospital for allegedly leaving her paralysed when she underwent surgery in 2015 to try and cure a longstanding and painful back problem.

James Howard Norman Sr has launched a lawsuit alleging that medical negligence by anaesthetist and pain specialist Dr Adnan Al-Kaisy, consultant spinal surgeon Khai Lam and the London Bridge hospital left his sister unable to move her body below the waist.

The doctors and hospital are disputing his claims.

The singer’s brother alleges that she suffered horrendous damage as a result of undergoing a procedure called epidurolysis, which is used to dissolve scar tissue around nerves in the spine.

His claim, which has been lodged at the high court in London, alleges that a series of mistakes meant “the deceased was effectively paralysed from the waist downwards, she could not walk, she could not stand even in a standing frame and she was wheelchair-bound”.

It continues: “She needed extensive care. She lived out her days in a rented apartment in New York since she could not access her home in Westchester County.”

The document claims that Al-Kaisy performed the epidurolysis despite the “limited evidence of the procedure’s efficacy, and little if any evidence of its safety”, despite the operation being little-used in the UK and the fact that it was not recommended by the National Institute of Health and Care Excellence (Nice) for back pain. It also accuses the doctor of not warning the singer of these weaknesses and not acquiring her informed consent to proceed with the procedure in those circumstances.

Norman’s brother contends that Lam also failed to warn the star about the limitations of the epidurolysis and that the procedure was the wrong treatment for the condition she was suffering from, called spinal stenosis. He claims Lam did not warn his sister “of the significant risk of paralysis arising from the procedure, in particular severe and permanent damage to the nerves involving paralysis and loss of the use of the lower part of the body”.

According to Norman his sister developed sciatica in March 2015 after undergoing surgery in New York the month before. A week later she came to London to fulfil some engagements and, on the advice of one of her doctors in her native United States, had a consultation with Lam at the London Bridge hospital. He noted that standing for a few minutes left her with pain and numbness in her right leg. He tried two treatments – steroid injections and inserting a “distraction device” – but neither relieved her symptoms.

Norman Sr’s claim says that Lam then suggested that the singer undergo epidurolysis, and suggested that Al-Kaisy could perform it. Both undertake private medical treatment and also work at Guy’s and St Thomas’ (GSTT), the leading NHS trust in London. Al-Kaisy performed the procedure at the London Bridge private hospital on 12 May 2015.

Both doctors are leading practitioners in their areas of medical expertise. Lam has regularly had articles published in medical journals and spoken at many medical conferences. The website for the GSTT’s private patient unit says that Al-Kaisy “has an international reputation as a leading expert in pain management”.

The legendary soprano was still in hospital in London after her treatment in 2015 when she first sought advice from law firm Leigh Day about taking legal action, and formally launched proceedings the next year. Her brother took over as the claimant when she died in 2019.

His claim also alleges that HCA, the giant American healthcare firm which owns and runs the London Bridge hospital, was negligent in not ensuring that the epidurolysis Lam and Al-Kaisy had recommended was safe, appropriate and evidence-based.

Olive Lewin, the specialist medical negligence solicitor at Leigh Day who is representing Norman Sr in the action, said: “The injuries Miss Norman sustained made her final years extremely difficult. It is a sad fact that despite wanting to, she was unable to continue engaging in the activities and events she loved most in the last four years of her life.

“Jessye Norman had painful sciatica, and was admitted to the London Bridge hospital for a pain-relieving procedure. She ended up being paralysed within hours of a procedure for which the claimant says there was no informed consent, and the efficacy of the procedure has not been proven.

“A negligence claim is being pursued as a result. This remains an ongoing claim, which is currently being defended.”

None of the defendants in the case responded directly to the claims when approached by the Guardian, but they are contesting the allegations against them and each has filed a defence.

HCA Healthcare UK owns and runs other private hospitals in the capital besides the London Bridge, including the Wellington, Princess Grace and Lister.

A HCA spokesperson said: “In order to ensure the confidentiality of every patient we care for, we would not comment on an inquiry into any individual’s care.”

Browne Jacobson solicitors, who are representing Al-Kaisy, said that patient confidentiality meant that he could not say anything but does deny the claims. His lawyer, Matthew Trinder, added: “I can tell you that all the allegations are strenuously denied and that a full defence has been served.”

Lam did not reply to requests to respond.

Health

WHO sets targets to end Mpox outbreaks in Africa

The World Health Organisation, WHO, has set a target of halting mpox outbreaks in Africa within the next six months.

This announcement came as the first vaccine shipments are expected to arrive in the Democratic Republic of Congo, DRC, in the coming days.

Africa, particularly the DRC, with over 18,000 suspected cases and 629 deaths, has received only a fraction of the vaccines to combat the virus.

At a press briefing on Monday, September 2, WHO Director-General, Dr Tedros Adhanom Ghebreyesus expressed confidence in ending the outbreaks, citing strong government leadership and collaborative partnerships.

In August, WHO declared mpox outbreaks a global emergency to spur a more robust international response even though a new strain of mpox known as clade1b, has been identified in many countries, including Burundi, Cameroon, Rwanda, and Kenya.

The potentially more contagious variant of the virus was detected in Congo in May, prompting heightened concerns among health officials.

WHO estimates that approximately 230,000 vaccines could soon be sent to Congo and other affected countries. The WHO is also implementing educational campaigns to inform people in outbreak areas about preventing the spread of the disease.

Africa’s Centers for Disease Control and Prevention has said it aims to receive 380,000 vaccine doses from donors, including the US and the EU, which falls short of the quantity required to eradicate the outbreaks.

Continue Reading

Health

No recorded case of mpox in Ogun- Govt

The Ogun State Commissioner for Health, Dr Tomo Coker, on Wednesday said the state has not recorded any case of Mpox across the 20 local government areas of the state.

She disclosed this in a statement made available to journalists in Abeokuta, saying that the state has maintained a high level of surveillance since the global outbreak in 2022.

“Mpox is a disease of public health importance and the World Health Organization (WHO) has declared outbreaks of a more virulent strain in some countries. Some states in Nigeria have also reported outbreaks of Mpox,” she said.

“Ogun State Ministry of Health is aware of this public health threat and has instituted appropriate measures to prevent it, detect it early, and respond as appropriate.

“The last case of Mpox in Ogun State was in May 2023 and no confirmed case has been reported in Ogun State to date.

“As of 18th August 2024, the state surveillance system has reported 151 suspected cases of Mpox across the state but none of the suspected cases has been confirmed to be Mpox though 53 returned positive for Chicken Pox.

“We are aware of the Chicken Pox cases in the state and the necessary measures are already in place.

“Sensitization of the public on Mpox, Chickenpox, and other priority diseases is ongoing through established platforms. Therefore, there is no need to panic.”

Continue Reading

Health

US donates 10,000 monkeypox vaccine doses to Nigeria

The United States government donated 10,000 doses of the Jynneos vaccine to Nigeria to aid in the fight against monkeypox on Tuesday.

The Jynneos vaccine, approved by the U.S. Food and Drug Administration, is designed to prevent smallpox and monkeypox in adults aged 18 and older who are at risk of infection.

During the official handover ceremony in Abuja, Prof. Muhammad Pate, the Coordinating Minister of Health and Social Welfare, expressed gratitude to the U.S. government for the generous donation.

Represented by Permanent Secretary Daju Kachollom, Pate emphasised the Federal Government’s commitment to improving public health in Nigeria.

He said, “This is a spirit of cooperation and collaboration through the years, and this vaccine will be of great help to us.

“The Federal Ministry of Health understands the importance of having a healthy nation, so all the policies that we implement and the collaborations are focused on ensuring our citizens’ health.”

Pate also extended thanks to other development partners, including USAID, PEPFAR, WHO, UNICEF, and various UN organisations, for their continued support.

He highlighted the importance of addressing public health concerns, particularly diseases like monkeypox that pose significant risks to the population.

Monkeypox, a rare viral zoonotic disease, primarily affects remote villages in Central and West Africa near tropical rainforests.

It is caused by the monkeypox virus, which belongs to the orthopoxvirus genus, including smallpox and cowpox.

Following the eradication of smallpox, monkeypox has become a prominent concern within the orthopoxvirus family.

On August 13, 2024, the Africa Centres for Disease Control and Prevention declared monkeypox a public health emergency of continental security.

As of last Friday, Nigeria’s Centre for Disease Control and Prevention reported 40 confirmed cases of monkeypox out of 830 suspected cases nationwide.

Continue Reading
Advertisement

Trending